Targeting Melanoma with 211 At/ 131 I-Methylene Blue: Preclinical and Clinical Experience
Author:
- 1 February 1999
- journal article
- research article
- Published by SAGE Publications in Hybridoma
- Vol. 18 (1) , 77-82
Abstract
The increasing incidence of melanoma and a lack of effective therapy have stimulated a search for new methods of early detection and treatment of the disease. Melanin synthesized in melanoma cells presents a unique target to which the treatment can be selectively addressed, provided the pigment is recognized by a suitable drug. Methylene blue possesses a high affinity for melanin and, therefore, accumulates preferentially in melanoma cells. Since not directly toxic to the tumor, methylene blue serves as a carrier for radioisotopes and, once taken up by melanoma cells, acts as a selectively localized source of radiation. Hence, radioderivatives of the compound can be used for diagnosis and therapy of disseminated melanoma.131I-methylene blue in conjunction with gamma camera imaging has already proved in clinical studies to be a useful tool for the detection of early melanoma dissemination.211At-methylene blue exceptional efficacy in treating melanoma and preventing its metastatic spread without damaging normal structures when administered systemically to human melanoma-bearing mice led to the approval of this α-particle emitting methylene blue derivative for the Phase I clinical trial.Keywords
This publication has 21 references indexed in Scilit:
- Immunological Gene Therapy Approaches for Malignant MelanomaSkin Pharmacology and Physiology, 1997
- 211At-methylene blue for targeted radiotherapy of disseminated melanoma: microscopic analysis of tumour versus normal tissue damageEuropean Journal of Cancer, 1996
- [211At]Methylene blue for targeted radiotherapy of human melanoma xenografts: Dose fractionation in the treatment of cutaneous tumoursEuropean Journal of Cancer, 1996
- Molecular and Biological Control of Melanogenesis Through Tyrosinase Genes and Intrinsic and Extrinsic Regulatory FactorsPigment Cell Research, 1994
- Radioimmunodetection and Radioimmunotherapy of Malignant Melanoma: A ReviewActa Oncologica, 1993
- Malignant melanomaThe Lancet, 1992
- The Melanin Binding of Drugs and Its ImplicationsDrug Metabolism Reviews, 1984
- Electron-donor-acceptor complex formation by compounds of biological interest II. The association constants of various 1,4-dinitrobenzene-phenothiazine drug complexesBiochimica et Biophysica Acta (BBA) - Biophysics including Photosynthesis, 1966
- Electron-donor-acceptor complex formation by compounds of biological interest I. Optical absorption spectra of mixtures of phenothiazines and related compounds with electron acceptorsBiochimica et Biophysica Acta (BBA) - Biophysics including Photosynthesis, 1966
- Ueber schmerzstillende Wirkung des MethylenblauDMW - Deutsche Medizinische Wochenschrift, 1890